Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Rajkumar

Showing results (71-80 of 169) with videos related to

Pageof 17
Sort By:
Leukemia|September 27, 2003
Expression of VEGF and its receptors by myeloma cellsS Kumar, T E Witzig, M Timm, et al.
Bone Marrow Transplantation|December 14, 2011
Secondary MGUS after autologous hematopoietic progenitor cell transplantation in plasma cell myeloma: a matter of undetermined significanceG V Manson, E Campagnaro, A Balog, et al.
Leukemia|August 21, 2012
High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myelomaG Bianchi, R A Kyle, D R Larson, et al.
Seminars in Oncology|April 30, 2003
Long-term follow-up of IgM monoclonal gammopathy of undetermined significanceR A Kyle, T M Therneau, S V Rajkumar, et al.
Materials (Basel, Switzerland)|October 16, 2024
Microstructure, Mechanical Properties and Corrosion Performance of Laser-Welded NiTi Shape Memory Alloy in Simulated Body FluidA Rajesh Kannan, N Siva Shanmugam, V Rajkumar, et al.
Leukemia|August 26, 2006
Thymoglobulin targets multiple plasma cell antigens and has in vitro and in vivo activity in multiple myelomaM M Timm, T K Kimlinger, J L Haug, et al.
Blood Cancer Journal|September 10, 2013
Pomalidomide: the new immunomodulatory agent for the treatment of multiple myelomaA A Chanan-Khan, A Swaika, A Paulus, et al.
Transplantation Proceedings|June 4, 2015
Conversion from tacrolimus to cyclosporine in patients with new-onset diabetes after renal transplant: an open-label randomized prospective pilot studyM Rathi, V Rajkumar, N Rao, et al.
Leukemia|April 27, 2007
ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cellsM P Kline, S V Rajkumar, M M Timm, et al.
Blood Cancer Journal|June 25, 2021
Serum BCMA levels predict outcomes in MGUS and smoldering myeloma patientsA Visram, C Soof, S V Rajkumar, et al.
Pageof 17

Showing results (71-80 of 169) with videos related to

Sort By:
Pageof 17
Leukemia|September 27, 2003
Expression of VEGF and its receptors by myeloma cellsS Kumar, T E Witzig, M Timm, et al.
Bone Marrow Transplantation|December 14, 2011
Secondary MGUS after autologous hematopoietic progenitor cell transplantation in plasma cell myeloma: a matter of undetermined significanceG V Manson, E Campagnaro, A Balog, et al.
Leukemia|August 21, 2012
High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myelomaG Bianchi, R A Kyle, D R Larson, et al.
Seminars in Oncology|April 30, 2003
Long-term follow-up of IgM monoclonal gammopathy of undetermined significanceR A Kyle, T M Therneau, S V Rajkumar, et al.
Materials (Basel, Switzerland)|October 16, 2024
Microstructure, Mechanical Properties and Corrosion Performance of Laser-Welded NiTi Shape Memory Alloy in Simulated Body FluidA Rajesh Kannan, N Siva Shanmugam, V Rajkumar, et al.
Leukemia|August 26, 2006
Thymoglobulin targets multiple plasma cell antigens and has in vitro and in vivo activity in multiple myelomaM M Timm, T K Kimlinger, J L Haug, et al.
Blood Cancer Journal|September 10, 2013
Pomalidomide: the new immunomodulatory agent for the treatment of multiple myelomaA A Chanan-Khan, A Swaika, A Paulus, et al.
Transplantation Proceedings|June 4, 2015
Conversion from tacrolimus to cyclosporine in patients with new-onset diabetes after renal transplant: an open-label randomized prospective pilot studyM Rathi, V Rajkumar, N Rao, et al.
Leukemia|April 27, 2007
ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cellsM P Kline, S V Rajkumar, M M Timm, et al.
Blood Cancer Journal|June 25, 2021
Serum BCMA levels predict outcomes in MGUS and smoldering myeloma patientsA Visram, C Soof, S V Rajkumar, et al.
Pageof 17